Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Dermatologic 1CNS 1

Conditions

Pain, Postoperative 3Colonic Neoplasms 3Esophageal Neoplasms 2Rectal Neoplasms 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Nutrition Disorders 1Melanoma 1Liver Neoplasms 1Liver Diseases 1Insulin Resistance 1Ileus 1Glioblastoma 1Gastroparesis 1Feeding and Eating Disorders 1Esophageal Squamous Cell Carcinoma 1Dumping Syndrome 1Diverticulosis, Colonic 1Diverticulitis, Colonic 1Constipation 1Colorectal Neoplasms 1Carcinoma, Squamous Cell 1Agnosia 1Adenocarcinoma 1

Interventions

Paclitaxel 11Fluorouracil 10pembrolizumab 9Cisplatin 9Radiotherapy 7Carboplatin 6Esophagectomy 5Nivolumab 4Drug Therapy 4Radiotherapy, Intensity-Modulated 3Leucovorin 3Chemoradiotherapy 3Cetuximab 3Capecitabine 3durvalumab 2atezolizumab 2Oxaliplatin 2Ipilimumab 2spartalizumab 1sintilimab 1selinexor 1regorafenib 1prexasertib 1osimertinib 1niraparib 1nilotinib 1nedaplatin 1nanocis 1fludarabine 1cobimetinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Squamous Cell × Acetaminophen × Gastrointestinal × Clear all
NCT01607905 2023-01-26

Safety Study of KPT-330 (Selinexor) in Patients With Advanced or Metastatic Solid Tumor Cancer

Karyopharm Therapeutics Inc

Phase 1 Completed
192 enrolled 29 charts
CNSDermatologicGastrointestinal

Adenocarcinoma, Carcinoma, Squamous Cell, Glioblastoma, Melanoma, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡